IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE, Inria Rennes – Bretagne Atlantique , INSERM - Institut National de la Santé et de la Recherche Médicale : U1228
Abstract : The therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery...
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01559941
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, July 11, 2017 - 9:56:15 AM Last modification on : Friday, January 15, 2021 - 3:33:28 AM
Emmanuelle Le Page, Gilles Edan. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes. Multiple Sclerosis Journal, SAGE Publications, 2017, 23 (8), pp.1056--1058. ⟨10.1177/1352458517695893⟩. ⟨hal-01559941⟩